Half Yearly Report

RNS Number : 0765W
Asia Dragon Trust PLC
21 April 2021
 

ASIA DRAGON TRUST PLC

LEI: 549300W4KB0D75D1N730

Capturing growth from world-class Asian companies

 

21 April 2021

 

HALF YEARLY FINANCIAL REPORT FOR THE SIX MONTHS ENDED 28 FEBRUARY 2021

 

Highlights

-  Asian stocks staged a strong rebound in the half-year under review, in stark contrast with the extreme volatility of the prior six months.

-  Over the six month period, the Trust delivered a strong net asset value (NAV) total return of 23.9% in sterling terms, outpacing the 18.0% increase in the benchmark, the MSCI AC Asia Pacific (ex Japan) Index (sterling adjusted) total return.

Longer-term performance is competitive. The Company's NAV has outperformed its index over 3, 5 and 10 years.  Over ten years to 28 February 2021, on a total return basis, the NAV increased by 155.9% compared a return of 148.62% from the benchmark.

-  Against the buoyant environment, your Company's holdings performed well due to their high-quality franchises and solid balance sheets. Many of them are beneficiaries of long-term structural trends that have been reinforced and hastened by the pandemic.

-  Over the long term, the region continued to offer immense opportunity. Asia is the world's growth engine, its global factory and a growing consumer force to be reckoned with. As incomes rise and wealth grows, demand from local consumers for health care, technology and aspirational consumer goods is increasing. Urbanisation and infrastructure needs remain vast.

-  Quality companies that can harness these structural trends, such as those that your Company holds, are well positioned to reap sustainable returns.

 

Investment Objective

Asia Dragon Trust's objective is long-term capital growth through investment in Asia, with the exception of Japan and Australasia.  Investments are made primarily in stock markets in the region, principally in large companies.  When appropriate, the Company will utilise gearing to maximise long term returns.

 

For further information please contact:-

 

Adrian Lim, Investment Director, Aberdeen Standard Investments (Asia) Limited  0065 6395 2700

Pruksa Iamthongthong, Investment Director, Aberdeen Standard Investments (Asia) Limited  0065 6395 2700

 

 

 

 

INTERIM BOARD REPORT - CHAIRMAN'S STATEMENT

 

Results

Asian stocks staged a strong rebound in the half-year under review, in stark contrast with the extreme volatility of the prior six months. Signs of a global economic recovery, the start of vaccine rollouts and the accommodative policy stance by both governments and central banks contributed to an improvement in investor sentiment and a rebound in the capital markets. Against this backdrop, the Trust delivered a net asset value (NAV) total return of 23.9% in sterling terms, outpacing the 18.0% increase in the benchmark, the MSCI All-Country Asia (ex Japan) Index (sterling adjusted).

 

At the same time, the Trust's share price increased by 27.2%. This helped to narrow its discount to NAV to 10.1%, from 12.3% at 31 August 2020.

 

Overview

Asian stock markets rallied in the six months under review. Positive news on the efficacy of several vaccines, as well as encouraging economic data, drew back investors who had been sitting on the sidelines. Notably, Asian stocks outpaced their global counterparts as major Western nations struggled with rising Covid-19 infection rates and were forced to re-impose lockdowns. Better-than-expected corporate earnings also underlined the region's lead in the global economic recovery.

 

Positive political developments globally further added to the optimism. Among these were the UK's trade agreement with the European Union as it exited from the bloc, Joe Biden's US election victory, which many had hoped would lead to a more considered approach towards China, and a massive US stimulus package that was passed into law at the time of writing. As a result, some markets, such as South Korea, touched multi-year highs.

 

Beneath the market's sheen, however, geopolitical tensions persisted. In the final days of the Trump administration, the US barred investments in 31 Chinese companies with alleged links to the military. It also passed legislation that would eject Chinese companies from US stock exchanges unless they met US auditing standards. Within Asia, the tensions between China and India increased, with the latter banning a number of Chinese apps, including some linked to Alibaba and Tencent.

 

Against the buoyant environment, your Company's holdings performed well due to their high-quality franchises and solid balance sheets. Many of them are beneficiaries of long-term structural trends that have been reinforced and hastened by the pandemic. As the pandemic kept people at home, it has driven a a boom in games consoles, laptops, monitors and televisions. Your Company's core technology holdings, Samsung Electronics and Taiwan Semiconductor Manufacturing Co (TSMC), benefited from the surge in demand. The recent shortage of semi-conductor chips suffered by carmakers has also underscored the strategic importance of chipmakers to the automobile supply chain. In the longer term, emergent technologies, such as 5G networks, cloud computing and artificial intelligence, should increase demand for more advanced semi-conductor chips.

 

Meanwhile, pharmaceutical contract research organisation Wuxi Biologics delivered robust growth in new drug development projects  as clients sought help to develop new Covid-19 treatments. During the period, your Manager invested in Samsung Biologics, as it expects outsourcing demand to rise among pharmaceutical firms, where biopharmaceutical products are increasingly produced, whether partially or completely, on behalf of another company. Since it started business eight years ago, Samsung Biologics has evolved into the world's largest biopharmaceutical contract manufacturer, matching other leading players in both scale and technological know-how, but with a clear cost advantage. This exposure to the company complements the portfolio's existing holdings in Wuxi Biologics and Hangzhou Tigermed, which occupy different parts of the same supply chain.

 

A new position was initiated in Alibaba. The Chinese e-commerce giant has quality assets, a solid business model and attractive growth prospects. Although your Manager had concerns about the group's corporate governance, it has observed improvements in recent years.Your Manager has been building a position in Alibaba on share-price weakness related to regulatory intervention as it believes the group offers good value in the longer term due to its economic reach and the quality of its management.

 

Meanwhile, selected mainland consumer-linked stocks also fared well, although the consumption recovery has been unevenly spread. Hong Kong-listed Kerry Logistics benefited from higher e-commerce volumes, as well as from SF Holding's acquisition of a controlling stake in the company. SF Holding, one of China's largest package-delivery services, plans to use Kerry as its primary vehicle for international expansion. Elsewhere, travel services and duty-free business operator China Tourism Group Duty Free, carmaker SAIC Motor and lender China Merchants Bank were also buoyed by the recovery in consumption. On the other hand, property companies  such as China Resources Land, were constrained by a tightening policy and liquidity environment. Shanghai International Airport continued to face short-term earnings pressure from Covid-19, which should ease as travel restrictions are lifted. In the longer term, the airport operator should benefit from recovering demand for international travel and duty-free spending amid growing affluence across Asia.

 

China, meanwhile, committed to becoming carbon-neutral by 2060, with emissions peaking before 2030. In view of this goal, which should underpin multi-year growth for renewable energy, your Manager introduced Longi Green Energy Technology to the portfolio. As the world's largest solar wafer maker, the company should be among the winners from Beijing's renewable energy push, given its technological and cost leadership.

 

To fund these initiations, your Manager sold holdings in lower conviction stocks: Singapore real estate group City Developments, Myanmar-based conglomerate Yoma Strategic, SAIC Motor and Bangkok Dusit Medical Services.

 

Revenue Account

For the six months to 28 February 2021, the revenue account recorded a return on ordinary activities after taxation of £2,861,000, representing 2.28p per share, compared with a return of £353,000 for the six months to 29 February 2020.  The increase in the revenue return is largely attributable to the change in the allocation of the management fee and financing costs.  Previously all these costs were allocated to revenue.  Following a review, the allocation was changed to 75% to capital and 25% to revenue, effective from 1 September 2020.  The revised allocation is in line with the AIC's statement of recommended practice which recommends that an investment trust recognises expenses between income and capital that reflects its expected returns over the longer term. 

 

Events during the Period

At the Company's Annual General Meeting on 10 December 2020, all resolutions were passed.

 

Discounts and Share Buybacks

The Board seeks to manage the Company's discount in line with its peer group.  The discount level of the Company's shares is closely monitored by the Board and Manager and share buybacks are undertaken when appropriate.  During the six month period to 28 February 2021, 1,018,529 shares were bought back and held in treasury. 

 

As at 19 April 2021, the Company's discount stood at 8.0%, with the AIC peer group sector average at 3.6%.

 

Gearing

The Board continues to believe that the sensible use of modest financial gearing should enhance returns to shareholders over the longer term.  The Company has in place a £50 million three-year loan facility, of which £25 million is fixed and fully drawn down and £25 million is revolving.  Under the facility agreement, the Trust also has the option to increase the revolving facility by a further £25 million to £50 million ('the accordion option'), subject to approval from the lending bank's credit committee.  In order to take advantage of the increasing attractive opportunities within the Asian stock markets, the Company implemented this accordion option under the facility in early January 2021.

 

At 28 February 2021, £40 million of the revolving facility was drawn and the Trust's net gearing position was 8.6%, compared to 3.5% at the end of August 2020.

 

The Manager continues to monitor closely gearing levels and bank covenants.  As at 19 April 2021 the Company's net assets stood at £726 million and net gearing was 7.0%, and the Company is pleased to report that these levels remain comfortably within the covenant limits.

 

Outlook

The world has come some way from the early days of the pandemic. However, we are by no means near the end of this unprecedented era, even as massive stimulus and support from governments and central banks globally fuel expectations of a growth recovery and rising consumer prices.

 

Your Manager is also monitoring the impact of inflation on two fronts. First, rising commodity prices could feed into raw material costs, hurting margins although many of your Company's holdings should be buffered by their ability to set prices, given their market leading positions. Second, rising prices could push central banks to reverse policy and raise interest rates, which would, in turn, increase the cost of borrowing. Both of these could affect the profitability of investee companies although your Company's holdings generally have strong balance sheets and therefore should be resilient to such changes.

 

Global developments, meanwhile, bear close watch. Chief among these is US foreign policy under President Biden, especially on China, and the progress of vaccine rollouts across Asia.

 

All of these imply near-term challenges for economies and markets in Asia. What is more pertinent for us as investors, however, is that over the long term, the region continues to offer immense opportunity.

 

Asia is the world's growth engine, its global factory and a growing consumer force to be reckoned with. As incomes rise and wealth grows, demand from local consumers for health care, technology and aspirational consumer goods is increasing. Urbanisation and infrastructure needs remain vast.

 

Quality companies that can harness these structural trends, such as those that your Company holds, are well positioned to reap sustainable returns.

 

 

For Asia Dragon Trust plc,

James Will

Chairman

20 April 2021

 

 

INTERIM BOARD REPORT

 

Principal Risks and Uncertainties

There are a number of risks which, if realised, could have a material adverse effect on the Company and its financial position, performance and prospects. The Board has in place a robust process to identify, assess and monitor the principal risks and uncertainties facing the Company and to identify and evaluate newly emerging risks.  A summary of the principal risks and uncertainties facing the Company is summarised below under the following headings:

 

-  Investment Performance

-  Concentration Risk

-  Major market event or geo-political risk

-  Resource

-  Reliance on Third Party Service Providers

-  Discount volatility

-  Gearing

-  Regulatory

-  Brexit

 

Details of these risks and a description of the mitigating action which the Company has taken are provided in detail on pages 14 to 15 of the 2020 Annual Report.  The principal risks have not materially changed during the six months to 28 February 2021.  The Board continues to monitor the risk environment and does not expect the risks facing the Company to materially change in the second half of the financial year ended 31 August 2021.

 

In addition to these risks, there are also a large number of international political and economic uncertainties which could have an impact on the performance of Asian markets.  The outbreak of the global Covid-19 virus has resulted in business disruption and stockmarket volatility across the world since early 2020.  The extent of the effect of the virus, including its long term impact, is difficult to predict.  The Manager has undertaken a detailed review of the investee companies in the Company's portfolio to assess the impact of Covid-19 on their operations such as employee absence, reduced demand, reduced turnover and supply chain breakdowns and will review carefully the composition of the Company's portfolio and will be pro-active where necessary. 

 

The outcome and potential impact of Brexit remains an economic risk for the Company, principally in relation to the potential impact of Brexit on currency volatility.  As an investment trust with an Asian mandate, the Company's portfolio is unlikely to be adversely impacted as a direct result of post Brexit regulation although some currency volatility could arise. The Board will continue to monitor developments as they occur so that the Company is ready to respond appropriately.

 

Going Concern

The Directors have undertaken a rigorous review of the Company's ability to continue as a going concern with particular focus on the impact of the Covid-19 pandemic.  The Company's assets consist substantially of equity shares in companies listed on recognised stock exchanges and in most circumstances are realisable within a short timescale.

 

The Company has a three year loan facility of £75 million in place until July 2022.  The Board has set limits for borrowing and regularly monitors the Company's covenant compliance and gearing levels and is satisfied that there is sufficient headroom in place and flexibility if required. A replacement option would be sought in advance of the expiry of the facility in July 2022, or, should the Board decide not to renew this facility, any outstanding borrowing would be repaid through the proceeds of equity sales as required. 

 

The Board has considered the impact of Covid-19 and believes that this will have a limited financial impact on the Company's operational resources and existence.  The Company's portfolio comprises primarily "Level One" assets (listed on a recognisable exchange and realisable within a short timescale), and the Company employs a relatively low level of gearing.  The Board has been regularly updated by the Manager on the resilience of the Manager's systems as well as those of the other key third party service providers and is satisfied that suitable business continuity plans are in place and have proved effective throughout the course of the pandemic.

 

The Directors are mindful of the principal risks and uncertainties disclosed above and, having reviewed forecasts detailing revenue and liabilities, they believe that the Company has adequate financial resources to continue its operational existence for the foreseeable future.  Accordingly, they continue to adopt the going concern basis of accounting in preparing the financial statements. 

 

Responsibility Statement of the Directors in respect of the Half Yearly Financial Report

We confirm that to the best of our knowledge:

 

-  the condensed set of financial statements has been prepared in accordance with FRS 104 Interim Financial Reporting;

-  the Interim Board Report (constituting the interim management report) includes a fair review of the information required by:

 

a)  DTR 4.2.7R of the Disclosure Guidance and Transparency Rules , being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

b)  DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

For Asia Dragon Trust plc,

James Will

Chairman
20 April 2021

 

 

 

FINANCIAL HIGHLIGHTS

 

 

28 February 2021

31 August 2020

% change

Equity shareholders' funds (£'000)

730,444

599,431

+21.9

Net asset value per share

582.77p

474.39p

+22.8

Share price (mid)

524.00p

416.00p

+26.0

Discount to net asset value per Ordinary share{A}

10.1%

12.3%

 

MSCI AC Asia (ex Japan) Index (sterling adjusted; capital return)

1187.30

1012.62

+17.3

Net gearing{A}

8.6%

3.5%

 

Ongoing charges ratio{A}

0.83%

0.89%

 

 

{A} Considered to be an Alternative Performance Measure.

 

 

Six months ended 28 February 2021

Year ended 31 August 2020

Net asset value total return per Ordinary share{A}

+23.9%

+4.7%

Share price total return per Ordinary share{A}

+27.2%

+4.6%

MSCI AC Asia Pacific (ex Japan) Index (sterling adjusted) total return

+18.0%

+10.9%

Discount to net asset value{A}

10.1%

12.3%

{A} Considered to be an Alternative Performance Measure.

 

 

 

PERFORMANCE HIGHLIGHTS

 

 

6 months ended

Year
ended

3 years
 ended

5 years
ended

10 years
ended

 

28 February 2021

28 February 2021

28 February 2021

28 February 2021

28 February 2021

Net asset value per share{A}

+23.9%

+33.2%

+39.8%

+132.4%

+155.9%

Share price{A}

+27.2%

+35.7%

+46.4%

+143.4%

+158.8%

MSCI AC Asia (ex Japan) Index (sterling adjusted)

+18.0%

+30.1%

+29.7%

+120.1%

+148.6%

 

{A} Considered to be an Alternative Performance Measure. 

 

 

 

INVESTMENT PORTFOLIO

As at 28 February 2021

 

 

 

 

 

Total

 

 

 

Valuation

assets

Company

Industry

Country

£'000

%

Taiwan Semiconductor Manufacturing Company

Semiconductors & Semiconductor Equipment

Taiwan

79,734

10.0

Tencent Holdings

Interactive Media & Services

China

75,073

9.4

Samsung Electronics (Pref)

Technology Hardware Storage & Peripherals

South Korea

73,848

9.2

AIA Group

Insurance

Hong Kong

34,975

4.4

Alibaba Group

Internet & Direct Marketing Retail

China

32,630

4.1

Housing Development Finance Corp

Thrifts & Mortgage Finance

India

25,713

3.2

Kweichow Moutai 'A'

Beverages

China

20,541

2.6

China Resources Land

Real Estate Management & Development

China

19,137

2.4

Ping An Insurance 'H'

Insurance

China

18,702

2.3

Bank Central Asia

Banks

Indonesia

18,570

2.3

Top ten investments

 

 

398,923

49.9

China Tourism Group Duty Free Corp 'A'

Speciality Retail

China

15,418

1.9

Meituan-Dianping Class B

Internet & Direct Marketing Retail

China

13,402

1.7

Wuxi Biologics (Cayman)

Life Sciences Tools & Services

China

13,383

1.7

Tata Consultancy Services

IT Services

India

13,210

1.7

Kotak Mahindra Bank

Banks

India

12,973

1.6

Midea Group 'A'

Household Durables

China

12,613

1.6

Hon Hai Precision Industry

Electronic Equipment, Instruments & Components

Taiwan

12,347

1.5

LG Chem

Chemicals

South Korea

12,124

1.5

Samsung SDI

Electronic Equipment, Instruments & Components

South Korea

11,358

1.4

Oversea-Chinese Banking Corporation

Banks

Singapore

11,037

1.4

Twenty largest investments

 

 

526,788

65.9

Hong Kong Exchanges & Clearing

Capital Markets

Hong Kong

10,633

1.3

Kerry Logistics Network

Air Freight & Logistics

Hong Kong

10,380

1.3

Ayala Land

Real Estate Management & Development

Philippines

10,256

1.3

Ultratech Cement

Construction Materials

India

9,837

1.2

China Conch Venture Holdings

Construction & Engineering

China

9,263

1.2

Sands China

Hotels, Restaurants & Leisure

China

8,762

1.1

Yunnan Energy New Material

Containers & Packaging

China

8,416

1.1

China Merchants Bank 'H'

Banks

China

8,004

1.0

Longi Green Energy Technology

Semiconductors & Semiconductor Equipment

China

7,969

1.0

China Vanke 'H'

Real Estate Management & Development

China

7,845

1.0

Thirty largest investments

 

 

618,153

77.4

Shenzhou International Group

Textiles, Apparel & Luxury Goods

China

7,733

1.0

ITC

Tobacco

India

7,646

1.0

Silergy Corp

Semiconductors & Semiconductor Equipment

Taiwan

7,433

0.9

Vietnam Technological & Commercial Bank

Banks

Vietnam

7,309

0.9

DBS Group

Banks

Singapore

7,168

0.9

SBI Life Insurance

Insurance

India

7,154

0.9

China Resources Gas

Gas Utilities

China

6,881

0.9

Info Edge (India)

Interactive Media & Services

India

6,592

0.8

Singapore Telecommunications

Diversified Telecommunication Services

Singapore

6,584

0.8

Budweiser Brewing

Beverages

Hong Kong

6,320

0.8

Forty largest investments

 

 

688,973

86.3

Bank of Philippine Islands

Banks

Philippines

6,173

0.8

GDS Holdings ADS

IT Services

China

6,035

0.8

Siam Cement 'F'

Construction Materials

Thailand

5,883

0.7

Shanghai International Airport 'A'

Transport Infrastructure

China

5,753

0.7

New Oriental Education & Technology Group Inc ADR

Diversified Telecommunication Services

China

5,421

0.7

Accton Technology Corp

Communications Equipment

Taiwan

5,319

0.7

Samsung Biologics

Life Sciences Tools & Services

South Korea

5,188

0.7

Hindustan Unilever

Household Products

India

5,137

0.6

CapitaLand

Real Estate Management & Development

Singapore

5,091

0.6

John Keells Holdings

Industrial Conglomerates

Sri Lanka

5,031

0.6

Fifty largest investments

 

 

744,004

93.2

Vietnam Dairy Products

Food Products

Vietnam

4,927

0.6

Astra International

Automobiles

Indonesia

4,915

0.6

Hangzhou Tigermed Consulting Co{A}

Life Sciences Tools & Services

China

4,535

0.5

KE Holdings

Real Estate Management & Development

China

4,271

0.5

Wanhua Chemical Group

Chemicals

China

4,164

0.5

Prestige Estate Projects

Real Estate Management & Development

India

4,085

0.5

Mobile World Investment Corporation

Speciality Retail

Vietnam

3,978

0.5

Nari Technology

Electrical Equipment

China

3,906

0.5

Beijing Sinnet Technology 'A'

IT Services

China

3,568

0.5

ASM Pacific Technology

Semiconductors & Semiconductor Equipment

Hong Kong

3,320

0.4

Sixty largest investments

 

 

785,673

98.3

Commercial Bank of Ceylon

Banks

Sri Lanka

2,886

0.4

Koh Young Technology

Semiconductors & Semiconductor Equipment

South Korea

2,773

0.4

JD Health International

Internet & Direct Marketing Retail

China

2,550

0.3

Joinn Laboratories

Life Sciences Tools & Services

China

728

0.1

Indocement Tunggal Prakarsa

Construction Materials

Indonesia

700

0.1

 

 

 

795,310

99.6

Net current assets{B}

 

 

3,553

0.4

Total assets less current liabilities{B}

 

 

798,863

100.0

 

 

 

 

 

{A} Holding includes investment in both 'A' and 'H' shares.

{B} Excluding bank loan of £40,000,000.

Note: Unless otherwise stated, foreign stock is held and all investments are equity holdings.

 

 

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED)

 

 

 

Six months ended

 

 

28 February 2021

 

 

Revenue

Capital

Total

 

Note

£'000

£'000

£'000

Gains/(losses) on investments

 

-

143,315

143,315

Net currency losses

 

-

(51)

(51)

Income

2

4,800

-

4,800

Investment management fee

 

(591)

(1,773)

(2,364)

Administrative expenses

 

(560)

-

(560)

 

 

_________

_________

_________

Net return/(loss) before finance costs and taxation

 

3,649

141,491

145,140

 

 

 

 

 

Interest payable and similar charges

 

(83)

(249)

(332)

 

 

_________

_________

_________

Net return/(loss) before taxation

 

3,566

141,242

144,808

 

 

 

 

 

Taxation

3

(705)

(2,369)

(3,074)

 

_________

_________

_________

Net return/(loss) attributable to equity shareholders

2,861

138,873

141,734

 

 

_________

_________

_________

Return per Ordinary share (pence)

4

2.28

110.49

112.77

 

 

_________

_________

_________

 

 

 

 

 

The total columns of this statement represent the profit and loss account of the Company. There is no other comprehensive income and therefore the return attributable to equity shareholders is also the total comprehensive income for the period.

All revenue and capital items in the above statement derive from continuing operations.

The accompanying notes are an integral part of the condensed financial statements.

 

 

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED)

 

 

 

Six months ended

 

 

29 February 2020

 

 

Revenue

Capital

Total

 

Note

£'000

£'000

£'000

Gains/(losses) on investments

 

-

(15,496)

(15,496)

Net currency losses

 

-

(299)

(299)

Income

2

3,639

-

3,639

Investment management fee

 

(2,027)

-

(2,027)

Administrative expenses

 

(585)

9

(576)

 

 

_________

_________

_________

Net return/(loss) before finance costs and taxation

 

1,027

(15,786)

(14,759)

 

 

 

 

 

Interest payable and similar charges

 

(280)

-

(280)

 

 

_________

_________

_________

Net return/(loss) before taxation

 

747

(15,786)

(15,039)

 

 

 

 

 

Taxation

3

(394)

(216)

(610)

 

_________

_________

_________

Net return/(loss) attributable to equity shareholders

353

(16,002)

(15,649)

 

 

_________

_________

_________

Return per Ordinary share (pence)

4

0.28

(12.50)

(12.22)

 

 

_________

_________

_________

 

 

 

CONDENSED STATEMENT OF FINANCIAL POSITION (UNAUDITED)

 

 

 

As at

As at

 

 

28 February 2021

31 August 2020

 

Notes

£'000

£'000

Non-current assets

 

 

 

Investments at fair value through profit or loss

 

795,310

620,827

 

 

_________

_________

Current assets

 

 

 

Debtors and prepayments

 

5,477

3,929

Cash and cash equivalents

 

1,488

11,390

 

 

_________

_________

 

 

6,965

15,319

 

 

_________

_________

Creditors: amounts falling due within one year

 

 

 

Other creditors

 

(3,412)

(4,666)

Bank loan

10

(40,000)

(6,000)

 

 

_________

_________

 

 

(43,412)

(10,666)

 

 

_________

_________

Net current (liabilities)/assets

 

(36,447)

4,653

 

_________

_________

Creditors: amounts falling due after more than one year

 

 

Bank loan

10

(24,996)

(24,995)

Deferred tax liability on Indian capital gains

3

(3,423)

(1,054)

 

 

_________

_________

 

 

(28,419)

(26,049)

 

 

_________

_________

Net assets

 

730,444

599,431

 

 

_________

_________

 

 

 

 

Capital and reserves

 

 

 

Called-up share capital

 

31,922

31,922

Share premium account

 

60,416

60,416

Capital redemption reserve

 

28,154

28,154

Capital reserve

6

575,476

441,359

Revenue reserve

 

34,476

37,580

 

 

_________

_________

Equity shareholders' funds

 

730,444

599,431

 

 

_________

_________

Net asset value per Ordinary share (pence)

7

582.77

474.39

 

 

_________

_________

 

 

 

CONDENSED STATEMENT OF CHANGES IN EQUITY (UNAUDITED)

 

Six months ended 28 February 2021

 

 

 

 

 

 

 

 

 Share

 Capital

 

 

 

 

 Share

 premium

 redemption

 Capital

 Revenue

 

 

 capital

 account

 reserve

 reserve 

 reserve

 Total

 

 '000

 '000

 '000

 '000

 '000

 '000

Balance at 31 August 2020

31,922

60,416

28,154

441,359

37,580

599,431

Return after taxation

-

-

-

138,873

2,861

141,734

Dividend paid (note 8)

-

-

-

-

(5,965)

(5,965)

Buyback of Ordinary shares for treasury

-

-

-

(4,756)

-

(4,756)

 

_______

_______

_______

_______

_______

_______

Balance at 28 February 2021

31,922

60,416

28,154

575,476

34,476

730,444

 

_______

_______

_______

_______

_______

_______

 

 

 

 

 

 

 

Six months ended 29 February 2020

 

 

 

 

 

 

 

 

 Share

 Capital

 

 

 

 

 Share

 premium

 redemption

 Capital

 Revenue

 

 

 capital

 account

 reserve

 reserve 

 reserve

 Total

 

 '000

 '000

 '000

 '000

 '000

 '000

Balance at 31 August 2019

31,922

60,416

28,154

431,945

37,271

589,708

(Loss)/return after taxation

-

-

-

(16,002)

353

(15,649)

Dividend paid (note 8)

-

-

-

-

(6,088)

(6,088)

Buyback of Ordinary shares for treasury

-

-

-

(4,086)

-

(4,086)

 

_______

_______

_______

_______

_______

_______

Balance at 29 February 2020

31,922

60,416

28,154

411,857

31,536

563,885

 

_______

_______

_______

_______

_______

_______

 

 

 

CONDENSED STATEMENT OF CASH FLOWS (UNAUDITED)

 

 

Six months ended

Six months ended

 

28 February 2021

29 February 2020

 

£'000

£'000

Operating activities

 

 

Net return before taxation

144,808

(15,039)

Adjustments for:

 

 

(Gains)/losses on investments

(143,315)

15,496

Currency losses

51

299

(Increase)/decrease in accrued dividend income

(1,427)

173

Decrease in other debtors

19

15

Increase/(decrease) in other creditors

190

(42)

Interest payable and similar charges

318

280

Stock dividends included in investment income

(327)

-

Overseas withholding tax

(416)

(307)

 

_________

_________

Cash (used in)/from operations

(99)

875

 

 

 

Interest paid

(318)

(282)

 

_________

_________

Net cash (outflow)/inflow from operating activities

(417)

593

 

 

 

Investing activities

 

 

Purchases of investments

(148,894)

(67,830)

Sales of investments

116,181

79,337

Capital gains tax on sales

-

(49)

 

_________

_________

Net cash (used in)/from investing activities

(32,713)

11,458

 

_________

_________

Financing activities

 

 

Equity dividend paid

(5,965)

(6,088)

Buyback of Ordinary shares to treasury

(4,756)

(4,086)

Drawdown of loan

34,000

-

Tender Offer for Ordinary shares inclusive of expenses

-

(5)

 

_________

_________

Net cash from/(used in) financing activities

23,279

(10,179)

 

_________

_________

(Decrease)/increase in cash and cash equivalents

(9,851)

1,872

 

_________

_________

Analysis of changes in cash and cash equivalents during the period

 

Opening balance

11,390

10,170

Effect of exchange rate fluctuations on cash held

(51)

(299)

(Decrease)/increase in cash and cash equivalents as above

(9,851)

1,872

 

_________

_________

Closing balance

1,488

11,743

 

_________

_________

Represented by:

 

 

Money market funds

100

2,300

Cash and short term deposits

1,388

9,443

 

_________

_________

 

1,488

11,743

 

_________

_________

 

 

NOTES TO THE FINANCIAL STATEMENTS

 

1.

Accounting policies

 

Basis of preparation. The condensed financial statements have been prepared in accordance with Financial Reporting Standard 104 (Interim Financial Reporting) and with the principles of the Statement of Recommended Practice for 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. Given that the Company's portfolio comprises primarily "Level 1" assets (listed on a recognisable exchange and realisable within a short timescale), and the Company's relatively low level of gearing, the Directors believe that adopting a going concern basis of accounting remains appropriate. The condensed financial statements have also been prepared on the assumption that approval as an investment trust will continue to be granted by HMRC.

 

The interim financial statements have been prepared using the same accounting policies as the preceding annual financial statements.

 

2.

Income

 

 

 

 

Six months ended

Six months ended

 

 

28 February 2021

29 February 2020

 

 

£'000

£'000

 

Income from investments

 

 

 

UK dividend income

-

38

 

Overseas dividends

4,799

3,582

 

 

_________

_________

 

 

4,799

3,620

 

 

_________

_________

 

Other income

 

 

 

Deposit interest

-

8

 

Interest from money market funds

1

9

 

Other income

-

2

 

 

_________

_________

 

 

1

19

 

 

_________

_________

 

Total income

4,800

3,639

 

 

_________

_________

 

3.

Taxation. The taxation for the period represents withholding tax suffered on overseas dividend income and a movement in provision for Indian Capital Gains Tax. 

 

An amount of £705,000 of withholding tax was suffered in the six months to 28 February 2021 (29 February 2020 - £394,000). The Indian Capital Gains Tax accrual has increased by £2,369,000 (29 February 2020 - increase of £167,000) since the year end with a balance outstanding at 28 February 2021 of £3,423,000 (29 February 2020 - £1,951,000).

 

4.

Return per Ordinary share

 

 

 

 

Six months ended

Six months ended

 

 

28 February 2021

29 February 2020

 

 

p

p

 

Basic

 

 

 

Revenue return

2.28

0.28

 

Capital return

110.49

(12.50)

 

 

_________

_________

 

Total return

112.77

(12.22)

 

 

_________

_________

 

The figures above are based on the following:

 

 

 

 

£'000

£'000

 

Revenue return

2,861

353

 

Capital return

138,873

(16,002)

 

 

_________

_________

 

Total return

141,734

(15,649)

 

 

___________

___________

 

Weighted average number of Ordinary shares in issue

125,681,941

128,111,741

 

 

___________

___________

 

 

 

 

 

The Company has no securities in issue that could dilute the return per Ordinary share. Therefore, for the six months ended 28 February 2021 (29 February 2020 - same) no diluted calculation is provided.

 

5.

Transaction costs. During the period expenses were incurred in acquiring or disposing of investments classified as fair value through profit or loss. These have been expensed through capital and are included within gains/(losses) on investments in the Condensed Statement of Comprehensive Income. The total costs were as follows:

 

 

 

 

 

 

Six months ended

Six months ended

 

 

28 February 2021

29 February 2020

 

 

£'000

£'000

 

Purchases

201

113

 

Sales

201

127

 

 

_________

_________

 

 

402

240

 

 

_________

_________

 

6.

Capital reserves. The capital reserve reflected in the Condensed Statement of Financial Position at 28 February 2021 includes gains of £294,442,000 (31 August 2020 - £179,491,000) which relate to the revaluation of investments held at the reporting date.

 

7.

Net asset value. The net asset value per share and the net assets attributable to the Ordinary shareholders at the period end were as follows:

 

 

As at

As at

 

 

28 February 2021

31 August 2020

 

Net assets attributable (£'000)

730,444

599,431

 

Number of Ordinary shares in issue{A}

125,339,924

126,358,453

 

Net asset value per share (pence)

582.77

474.39

 

{A} Excluding shares held in treasury.

 

 

 

8.

Dividends

 

 

 

 

Six months ended

Six months ended

 

 

28 February 2021

29 February 2020

 

 

£'000

£'000

 

2019 final dividend - 4.75p

-

6,088

 

2020 final dividend - 4.75p

5,965

-

 

 

_________

_________

 

 

5,965

6,088

 

 

_________

_________

 

 

 

 

 

There will be no interim dividend for the year to 31 August 2021 (2020 - nil) as the objective of the Company is long-term capital appreciation.

 

9.

Fair value hierarchy. FRS 102 requires an entity to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following classifications:

 

Level 1: unadjusted quoted prices in an active market for identical assets or liabilities that the entity can access at the measurement date.

 

Level 2: inputs other than quoted prices included within Level 1 that are observable (ie developed using market data) for the asset or liability, either directly or indirectly.

 

Level 3: inputs are unobservable (ie for which market data is unavailable) for the asset or liability.

 

All of the Company's investments are in quoted equities (31 August 2020 - same) which are actively traded on recognised stock exchanges, with their fair value being determined by reference to their quoted bid prices at the reporting date. The total value of the investments as at 28 February 2021 of £795,310,000 (31 August 2020 - £620,827,000) has therefore been deemed as Level 1.

 

10.

Bank loans. The Company has a £50,000,000 multicurrency revolving facility with Scotiabank Europe Plc. This agreement was entered into on 30 July 2019 with a termination date of 29 July 2022. At 28 February 2021, £40,000,000 of this facility has been drawn down at a rate of 0.9965% which matures on 26 March 2021.

 

The Company has a fixed loan facility agreement  of £25,000,000 at an interest rate of 1.61% with Scotiabank Europe Plc, with a termination date of 29 July 2022.  The agreement of this facility incurred an arrangement fee of £7,500, which is being amortised over the life of the loan.

 

The agreements contain the following covenants:

 

-   the net asset value of the Company shall not at any time be less than £385 million.

 

-   the adjusted asset coverage of the Company, as defined in the loan facility agreement, shall not at any time be less than 4.00 to 1.00.

 

All covenants have been complied with throughout the period.

 

11.

Called-up share capital. In the six months to 28 February 2021, the Company bought back 1,018,529 (29 February 2020 - 995,794) Ordinary shares to be held in treasury, at a total cost of £4,756,000 (29 February 2020 - £4,086,000).

 

At the end of the period there were 159,611,677 (29 February 2020 - 159,611,677) Ordinary shares in issue, of which 34,271,753 (29 February 2020 - 31,858,623) were held in treasury.

 

Since the period end a further 56,430 Ordinary shares of 20p each have been purchased by the Company at a total cost of £304,000 all of which were held in treasury.

 

12.

Analysis of changes in net debt 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At

 

 

 

At

 

 

31 August 2020

Currency
differences

Cash
flows

Non-cash
movements

28 February 2021

 

 

£'000

£'000

£'000

£'000

£'000

 

Cash and short term deposits 

11,390

(51)

(9,851)

-

1,488

 

Debt due within one year 

(6,000)

-

(34,000)

-

(40,000)

 

Debt due after more than one year 

(24,995)

-

-

(1)

(24,996)

 

 

_________

________

________

________

________

 

 

(19,605)

(51)

(43,851)

(1)

(63,508)

 

 

_________

________

________

________

________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At

 

 

 

At

 

 

31 August 2019

Currency
differences

Cash
flows

Non-cash
movements

29 February 2020

 

 

£'000

£'000

£'000

£'000

£'000

 

Cash and short term deposits 

10,170

(299)

1,872

-

11,743

 

Debt due within one year 

(6,000)

-

-

-

(6,000)

 

Debt due after more than one year 

(24,993)

-

-

(1)

(24,994)

 

 

_________

________

________

________

________

 

 

(20,823)

(299)

1,872

(1)

(19,251)

 

 

_________

________

________

________

________

 

 

 

 

 

 

 

 

A statement reconciling the movement in net funds to the net cash flow has not been presented as there are no differences from the above analysis.

 

13.

Related party transactions and transactions with the Manager. The Company has an agreement with Aberdeen Standard Fund Managers Limited ("ASFML" or the "Manager") for the provision of management and administration services, promotional activities and secretarial services.

 

The management fee for the six months ended 28 February 2021 is calculated at 0.85% per annum of net assets up to £350 million and 0.50% per annum of net assets over this threshold. Management fees are calculated and payable on a quarterly basis. On 1 September 2020, the management fee capitalisation rate was changed to 75% chargeable to capital and 25% to revenue. During the period £2,364,000 (29 February 2020 - £2,027,000) of management fees were payable to the Manager, with a balance of £1,219,000 (29 February 2020 - £1,011,000) due to ASFML at the period end.

 

The management agreement is terminable by the Company on three months' notice or in the event of a change of control in the ownership of the Manager. The notice period required to be given by the Manager is six months.

 

At the end of the period the Company had £100,000 (29 February 2020 - £2,300,000) invested in Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund which is managed and administered by Aberdeen Standard Investments. The Company pays a management fee on the value of these holdings but no fee is chargeable at the underlying fund level.

 

Promotional activities costs are based on current annual amount of £200,000 (29 February 2020 - £200,000), payable quarterly in arrears. During the period £100,000 (29 February 2020 - £100,000) of fees were payable, with a balance of £32,000 (29 February 2020 - £33,000) being due at the period end.

 

14.

Segmental information. The Company is engaged in a single segment of business, which is to invest in equity securities. All of the Company's activities are interrelated, and each activity is dependent on the others. Accordingly, all significant operating decisions are based on the Company as one segment.

 

15.

Half-Yearly Financial Report. The financial information contained in this Half-Yearly Financial Report does not constitute statutory accounts as defined in Sections 434 - 436 of the Companies Act 2006. The financial information for the six months ended 28 February 2021 and 29 February 2020 has not been audited. The Company's external auditor, PricewaterhouseCoopers LLP has not reviewed the financial information for the six months ended 28 February 2021.

 

The information for the year ended 31 August 2020 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the auditor on those accounts contained no qualification or statement under Section 498(2) or (3) of the Companies Act 2006.

 

16.

This Half-Yearly Financial Report was approved by the Board on 20 April 2021.

 

 

ALTERNATIVE PERFORMANCE MEASURES

 

 

 

 

Alternative Performance Measures ("APMs") are numerical measures of the Company's current, historical or future performance, financial position or cash flows, other than financial measures defined or specified in the applicable financial framework. The Company's applicable financial framework includes FRS 102 and the AIC SORP. The Directors assess the Company's performance against a range of criteria which are viewed as particularly relevant for closed-end investment companies.

Total return. NAV and share price total returns show how the NAV and share price has performed over a period of time in percentage terms, taking into account both capital returns and dividends paid to shareholders. NAV total return involves investing the net dividend in the NAV of the Company with debt at fair value on the date on which that dividend goes ex-dividend. Share price total return involves reinvesting the net dividend in the share price of the Company on the date on which that dividend goes ex-dividend.

The tables below provide information relating to the NAVs and share prices of the Company on the dividend reinvestment dates during the six months ended 28 February 2021 and 29 February 2020 and total return for the period.

 

 

 

 

 

Dividend

 

Share

2021

rate

NAV

price

31 August 2020

N/A

474.39p

416.00p

19 November 2020

4.75p

540.71p

479.50p

28 February 2021

N/A

582.77p

524.00p

 

 

________

________

Total return

 

+23.9%

+27.2%

 

 

________

________

 

 

 

 

 

Dividend

 

Share

2020

rate

NAV

price

31 August 2019

N/A

458.03p

402.50p

21 November 2019

4.75p

445.34p

396.50p

29 February 2020

N/A

441.39p

390.00p

 

 

________

________

Total return

 

-2.6%

-1.9%

 

 

________

________

 

 

 

 

Discount to net asset value per Ordinary share. The difference between the share price of 524.00p (31 August 2020 - 416.00p) and the net asset value per Ordinary share of 582.77p (31 August 2020 - 474.39p) expressed as a percentage of the net asset value per Ordinary share.

Net gearing. Net gearing measures the total borrowings of £64,996,000 (31 August 2020 - £30,995,000) less cash and cash equivalents of £3,228,000 (31 August 2020 - £10,257,000) divided by shareholders' funds of £730,444,000 (31 August 2020 - £599,431,000), expressed as a percentage. Under AIC reporting guidance cash and cash equivalents includes net amounts due from brokers at the period end of £1,740,000 (31 August 2020 - due to brokers - £1,133,000) as well as cash and short term deposits of £1,488,000 (31 August 2020 - £11,390,000).

Ongoing charges. The ongoing charges ratio has been calculated in accordance with guidance issued by the AIC as the total of investment management fees and administrative expenses and expressed as a percentage of the average net asset values with debt at fair value throughout the year. The ratio for 28 February 2021 is based on forecast ongoing charges for the year ending 31 August 2021.

 

 

 

 

28 February

31 August

 

2021

2020

Investment management fees (£'000)

4,803

4,058

Administrative expenses (£'000)

1,094

1,070

Less: non-recurring charges (£'000)

(18)

(49)

 

________

________

Ongoing charges (£'000)

5,879

5,079

 

________

________

Average net assets (£'000)

711,993

573,046

 

________

________

Ongoing charges ratio

0.83%

0.89%

 

________

________

 

 

 

The ongoing charges ratio provided in the Company's Key Information Document is calculated in line with the PRIIPs regulations which among other things, includes the cost of borrowings and transaction costs.

      

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EBLFLFZLFBBX
Investor Meets Company
UK 100